Skip to content
Search

Latest Stories

Over 700 pharmacies in Wales to offer electronic prescriptions to patients

Over 700 pharmacies in Wales to offer electronic prescriptions to patients

Adopting electronic prescriptions will simplify the reimbursement process, enhance prescribing efficiency and decrease the likelihood of errors

Following successful testing, Invatech Health's patient medication record (PMR) system, Titan, has been approved for nationwide Electronic Prescription Service (EPS) roll out in Wales.


The Bristol-based tech company announced on Thursday, 18 April that the software will be implemented in over 700 pharmacies across the country.

For pharmacists, adopting electronic prescriptions will simplify the reimbursement process, enhance prescribing efficiency, optimise stock control, reduce paper use and thereby decrease the likelihood of errors.

Meanwhile, the service will allow patients to collect prescriptions from their preferred community pharmacy without relying on a paper form, as well as obtain repeat prescriptions directly from the pharmacy without the need to visit their GP surgery.

Titan is the first PMR system approved for EPS use in Wales, according to Tariq Muhammad, CEO of Invatech Health and a former community pharmacist.

He described the certification of Titan for EPS use as “a landmark moment for the sector in Wales.”

Titan was signed off by the Board of Digital Health and Care Wales (DHCW) in the middle of March and officially certified in early April. The EPS certification follows three months of successful testing at Lakeside Medical Centre and Wellington Road Pharmacy in Rhyl, the company said in their press release.

A new era for pharmacies in Wales

Malpas Pharmacy in Newport is one of the first pharmacies in South Wales to go live with the new system.

“It’s the start of a new era for us,” said Geoff Thomas of Malpas Pharmacy.

Thomas announced they will soon be offering patients the opportunity to nominate either Malpas or Malpas Brook as their chosen pharmacy to receive the electronic transfer of their prescriptions.

“Once the GPs surgeries have deployed the system too, we’ll all be ready to realise the benefits,” he said.

He believes that EPS technology will make life much easier for patients, improve efficiency at GP surgeries, and allow them to advance their businesses while enhancing the services they offer.

Titan PMR is already used by a large number of community pharmacies across Wales.

Tariq noted that the approval of their PMR system for EPS use in Wales will bring great benefits to its existing customers and their patients.

Encouraging other pharmacies to take on the benefits, he said: “The roll-out of EPS capability across the GP surgery network over coming months will give great competitive opportunities to community pharmacies across the country.”

In late 2019, Titan PMR became the first PMR system to be accredited by NHS England in 15 years. Since then, the software has been adopted by hundreds of community and online pharmacies nationwide, all made possible by significant funding from Innovate UK. Collectively, these pharmacies are dispensing almost 10 per cent of all prescriptions in the UK, according to the tech entrepreneur.

In 2021, Titan demonstrated the first paperless pharmacy, and the following year, it pioneered the use of Artificial Intelligence (AI) for clinical checking.

In April 2023, Titan was granted full release authority by the NHS to provide EPS to dispensing doctors catering to almost 10 million people in the UK’s rural communities.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less